Early diagnosis is crucial for managing neurodegenerative diseases. Nanotechnology enables the development of highly sensitive biosensors that can detect biomarkers in blood, cerebrospinal fluid, or other body fluids. These sensors often use quantum dots or gold nanoparticles to achieve high sensitivity and specificity, allowing for the detection of disease at an early stage.
